BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33461943)

  • 1. Investigation of TNF-α and IL-6 Levels in the Sera of Non-Melanoma Skin Cancer Patients.
    Ghahartars M; Abtahi S; Zeinali Z; Fattahi MJ; Ghaderi A
    Iran Biomed J; 2021 Mar; 25(2):88-92. PubMed ID: 33461943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of severity of chronic obstructive pulmonary disease with potential biomarkers.
    Singh S; Verma SK; Kumar S; Ahmad MK; Nischal A; Singh SK; Dixit RK
    Immunol Lett; 2018 Apr; 196():1-10. PubMed ID: 29329680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-helper 17 cytokines (interleukins 17, 21, 22, and 6, and tumor necrosis factor-α) in patients with alopecia areata: association with clinical type and severity.
    Atwa MA; Youssef N; Bayoumy NM
    Int J Dermatol; 2016 Jun; 55(6):666-72. PubMed ID: 26235375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-6, IL-8 and TNF-α levels correlate with disease stage in breast cancer patients.
    Ma Y; Ren Y; Dai ZJ; Wu CJ; Ji YH; Xu J
    Adv Clin Exp Med; 2017; 26(3):421-426. PubMed ID: 28791816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum inflammatory cytokines IL-1beta, IL-6, TNF-alpha and VEGF have influence on the development of diabetic retinopathy.
    Koleva-Georgieva DN; Sivkova NP; Terzieva D
    Folia Med (Plovdiv); 2011; 53(2):44-50. PubMed ID: 21797106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between increased circulating YKL-40, IL-6 and TNF-α levels and phenotypes and disease activity of primary Sjögren's syndrome.
    Chen C; Liang Y; Zhang Z; Zhang Z; Yang Z
    Int Immunopharmacol; 2020 Nov; 88():106878. PubMed ID: 32791244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus.
    Doganay S; Evereklioglu C; Er H; Türköz Y; Sevinç A; Mehmet N; Savli H
    Eye (Lond); 2002 Mar; 16(2):163-70. PubMed ID: 11988817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine profiles in patients with newly diagnosed multiple myeloma: Survival is associated with IL-6 and IL-17A levels.
    Gu J; Huang X; Zhang Y; Bao C; Zhou Z; Jin J
    Cytokine; 2021 Feb; 138():155358. PubMed ID: 33183958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of cytokine evolution (tumor necrosis factor-alpha and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma.
    Martin C; Boisson C; Haccoun M; Thomachot L; Mege JL
    Crit Care Med; 1997 Nov; 25(11):1813-9. PubMed ID: 9366763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum concentrations of interleukin (IL-)1alpha, 1beta, 6 and tumor necrosis factor (TNF-) alpha in patients with thyroid eye disease (TED).
    Laban-Guceva N; Bogoev M; Antova M
    Med Arh; 2007; 61(4):203-6. PubMed ID: 18297990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of interleukin-6, TNF-alpha and interleukin-1alpha with disease activity and severity in juvenile idiopathic arthritis patients.
    Spîrchez M; Samaşca G; Iancu M; Bolba C; Miu N
    Clin Lab; 2012; 58(3-4):253-60. PubMed ID: 22582498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proinflammatory cytokines (TNF-alpha and IL-6) in Egyptian patients with SLE: its correlation with disease activity.
    Sabry A; Sheashaa H; El-Husseini A; Mahmoud K; Eldahshan KF; George SK; Abdel-Khalek E; El-Shafey EM; Abo-Zenah H
    Cytokine; 2006 Aug; 35(3-4):148-53. PubMed ID: 17027280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease.
    Evereklioglu C; Er H; Türköz Y; Cekmen M
    Mediators Inflamm; 2002 Apr; 11(2):87-93. PubMed ID: 12061429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum interleukin-6 and tumor necrosis factor-α are associated with early graft regeneration after living donor liver transplantation.
    Chae MS; Moon KU; Chung HS; Park CS; Lee J; Choi JH; Hong SH
    PLoS One; 2018; 13(4):e0195262. PubMed ID: 29649247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with levamisole and colchicine can result in a significant reduction of IL-6, IL-8 or TNF-alpha level in patients with mucocutaneous type of Behcet's disease.
    Sun A; Wang YP; Chia JS; Liu BY; Chiang CP
    J Oral Pathol Med; 2009 May; 38(5):401-5. PubMed ID: 19434815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between levels of TNF-alpha and IL-6 and hematological involvement in SLE Egyptian patients with lupus nephritis.
    Sabry A; Elbasyouni SR; Sheashaa HA; Alhusseini AA; Mahmoud K; George SK; Kaleek EA; abo-Zena H; Kalil AM; Mohsen T; Rahim MA; El-samanody AZ
    Int Urol Nephrol; 2006; 38(3-4):731-7. PubMed ID: 17260180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine levels and systemic toxicity in patients undergoing isolated limb perfusion with high-dose tumor necrosis factor, interferon gamma, and melphalan.
    Thom AK; Alexander HR; Andrich MP; Barker WC; Rosenberg SA; Fraker DL
    J Clin Oncol; 1995 Jan; 13(1):264-73. PubMed ID: 7799030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum and ascitic fluid levels of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in patients with ovarian epithelial cancer.
    Moradi MM; Carson LF; Weinberg B; Haney AF; Twiggs LB; Ramakrishnan S
    Cancer; 1993 Oct; 72(8):2433-40. PubMed ID: 8402460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlations between skin lesions induced by anti-tumor necrosis factor-α and selected cytokines in Crohn's disease patients.
    Włodarczyk M; Sobolewska A; Wójcik B; Loga K; Fichna J; Wiśniewska-Jarosińska M
    World J Gastroenterol; 2014 Jun; 20(22):7019-26. PubMed ID: 24944497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of serum levels of IL-6, TNF-alpha, and erythropoietin in metastatic malignant melanoma: serum IL-6 level is a valuable prognostic factor at least as serum LDH in advanced melanoma.
    Tas F; Oguz H; Argon A; Duranyildiz D; Camlica H; Yasasever V; Topuz E
    Med Oncol; 2005; 22(3):241-6. PubMed ID: 16110135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.